Navigation Links
Quest Diagnostics Reports Strong Performance in Third Quarter 2009
Date:11/4/2009

.8) (434.9) (Decrease) increase in book overdrafts (16.4) 1.4 Purchases of treasury stock (350.0) - Exercise of stock options 46.6 27.9 Excess tax benefits from stock-based compensation arrangements 3.2 2.1 Dividends paid (56.2) (58.4) Distributions to noncontrolling interests (23.0) (23.6) Financing costs paid (0.2) (0.5) ----- ----- Net cash used in financing activities (503.8) (464.5) ------- ------- Net change in cash and cash equivalents (6.9) 119.1 Cash and cash equivalents, beginning of period 253.9 167.6 ----- ----- Cash and cash equivalents, end of period $247.0 $286.7 ====== ====== Cash paid during the period for: Interest $118.9 $151.7 Income taxes $283.1 $277.4 Notes to Financial Tables 1) On January 1, 2009, the Company adopted a new accounting standard related to noncontrolling interests in consolidated financial statements, the provisions of which, among other things, require that minority interests be renamed "net income attributable to noncontrolling interests" and that a company present a consolidated net income measure that includes the amount attributable to such noncontrolling interests for all periods presented. The adoption of
'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology news :

1. Quest Diagnostics Reports Strong Performance in Third Quarter 2009
2. Chimpanzees help each other on request but not voluntarily
3. Critical Zone Observatory seeks to answer climate change questions
4. Department of Energy supports carbon sequestration research, University of Miami receives $1.7 million
5. Aurora B answers an XIST-ential question
6. Carnegie Mellon team makes sequestration recommendations
7. International conference on CO2 sequestration processes
8. Forest fire prevention efforts will lessen carbon sequestration, add to greenhouse warming
9. Recent news reports of sweetener reformulations raise questions about motivations
10. Work of Field Museum scientist addresses question of chance in evolution
11. Ecologists question effects of climate change on infectious diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...the stomach, may be used to boost resistance to, o...le School of Medicine researchers report in a stud...euroscience . , Parkinson,s disease is caused by...the midbrain known as the substantia nigra, which ...roduction of dopamine in late-stage Parkinson,s ca...
(Date:11/25/2009)...e Cell Death Research Laboratory in the University...d the prestigious Johnson & Johnson Focused Fundin...ain cell damage in Parkinson,s disease. The award,...rt of innovation and excellence in science, was an...this month at an event at the Hyatt Regency Hotel ...
(Date:11/25/2009)...tant professors recently received funding from the...earch beneficial to understanding the environment....Blackwood, assistant professor in the Department o...rt two separate research projects. , His first p...nities and Functions from the Leaf to the Landscap...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 1Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 2Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 1Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 2Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 3
...ehind mad cow disease and its human variation, Cre...According to new findings from Gerald Zamponi and ...urons from working themselves to death. The findin...ell Biology., Diseases such as mad cow result when.... This infectious form creates a template that ind...
...rt in Support of "New Employee,Verification Act", ...iation devoted to human resource management today ...ionals to endorse the "New Employee,Verification A...Means,Subcommittee on Social Security, Sue Meising... recognize that the current employment verificatio...
...study by UC Davis researchers provides evidence th...lls to deliver gene therapy to cure diseases of th...o not cause the development of tumors or leukemia.... issue of Molecular Therapy. , "The results of ou...plantation shows that there is little risk of adve...
Other Biology News:SHRM CEO Testifies Before House Subcommittee on Social Security 2SHRM CEO Testifies Before House Subcommittee on Social Security 3UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells 2UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells 3
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCorpora...onferenceonTuesday,December1stat1:45PMGMTinLondon,...obroadcastovertheInternetavailableat http://inve ...he"Webcast"icontoaccessthisfile. ,, AboutSigm...ighTechnologycompany.Itschemicalandbiochemicalprod...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedt...sapprovedthe,investigationalnewdrugapplication(IND...ulinformulationtotreatdiabetes.ThisIND,approvalall...,, Diabetesisadisordercharacteristicofhighblood...esoftenresultinseveremicro-and,macro-vasculardisea...
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,...lcompany,today,announcedthatithassubmittedaMAAtoth...ompany,senzymereplacementtherapyindevelopment,fort...keting,applicationforvelaglucerasealfathathasbeens...andCanada. , Basedonaglobalsupplyshortageofth...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the glo...hina,s patent office is now the world,s leading pr...ry. China trailed Japan,s patent office, the World...e United States Patent and Trademark Office (USPTO...2005, WIPO in 2006, and exceeded Japan for the fir...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... and VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ - On... present at the BioContact Quebec,2008 annual part... Salle,Laval at the Chateau Frontenac in Quebec Ci...er, Scott Cormack, will provide a corporate overvi...e Company,s lead cancer drug,candidate OGX-011 nea...
...Oct. 1 SoluLinK, Inc., a leader in,conjugation pr...e,introduction of its newest product, the One-Shot... kit includes all the components for the rapid,tra... features SoluLinK,s,patented sulfo-ChromaLink Bio...nt that allows rapid and direct, non-destructive q...
...st is Cepheid,s Second FDA Cleared Diagnostic Test...han Twenty-Four Hours Over Conventional ...Oct. 1 Cepheid (Nasdaq:,CPHD) today announced it ...dministration (FDA) to market its Xpert(TM) MRSA/S...pert(R) System, for the detection of,Methicillin-r...
Other Biology Technology:SoluLinK Introduces New One-Shot ChromaLink(TM) Biotin Antibody Labeling Kit with Built-in Biotin Quantification. 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5
Rabbit Anti-Human NIRF Polyclonal Antibody, Unconjugated from Abcam
Acc I from Invitrogen
SexA I from New England Biolabs
Psp1406 I from Takara Mirus Bio
Biology Products: